GlaxoSmithKline PLC
GSK | IL
Overview
Corporate Details
- ISIN(s):
- GB00BN7SWP63 (+1 more)
- LEI:
- 5493000HZTVUYLO1D793
- Country:
- United Kingdom
- Address:
- 79 NEW OXFORD STREET, WC1A 1DG LONDON
- Website:
- https://www.gsk.com/en-gb/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive. Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-15 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.3 MB | |
| 2025-08-14 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 454.8 KB | |
| 2025-08-13 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.8 MB | |
| 2025-08-12 16:30 |
Director's Dealing
Director/PDMR Shareholding
|
English | 91.5 KB | |
| 2025-08-12 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.5 MB | |
| 2025-08-11 08:00 |
Regulatory News Service
FDA to review gonorrhea indication for gepotidacin
|
English | 31.0 KB | |
| 2025-08-11 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 1.6 MB | |
| 2025-08-08 08:00 |
Legal Proceedings Report
CureVac/BioNTech mRNA patent litigation settlement
|
English | 24.1 KB | |
| 2025-08-08 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
Japanese | 2.1 MB | |
| 2025-08-07 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.3 MB | |
| 2025-08-06 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.1 MB | |
| 2025-08-05 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.1 MB | |
| 2025-08-04 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 2.8 MB | |
| 2025-08-01 16:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 4.9 KB | |
| 2025-08-01 08:00 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 18.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Nippon Shinyaku Co.,Ltd. | Japan | 4516 | |
|
Noile-Immune Biotech Inc. | Japan | 4893 | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI | |
|
Nxera Pharma Co., Ltd. | Japan | 4565 | |
|
ObsEva SA | Switzerland | OBSN | |
|
ODI Pharma AB | Sweden | ODI | |
|
Oncolys BioPharma Inc. | Japan | 4588 | |
|
OncoTherapy Science, Inc. | Japan | 4564 | |
|
OncoZenge AB | Sweden | ONCOZ |